P029: Early treatment with alglucosidase alfa is associated with improved survival in patients with infantile-onset Pompe disease: Data from Pompe Registry

Bibliographic Details
Main Authors: Priya Kishnani, David Stockton, Andreas Hahn, Juan Llerena, Alexander Broomfield, Julie Batista, Meredith Foster, Kathryn Wilson, Susan Sparks, Hannerieke van den Hout, Yin-Hsiu Chien
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Genetics in Medicine Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2949774424000529
_version_ 1797267633811226624
author Priya Kishnani
David Stockton
Andreas Hahn
Juan Llerena
Alexander Broomfield
Julie Batista
Meredith Foster
Kathryn Wilson
Susan Sparks
Hannerieke van den Hout
Yin-Hsiu Chien
author_facet Priya Kishnani
David Stockton
Andreas Hahn
Juan Llerena
Alexander Broomfield
Julie Batista
Meredith Foster
Kathryn Wilson
Susan Sparks
Hannerieke van den Hout
Yin-Hsiu Chien
author_sort Priya Kishnani
collection DOAJ
first_indexed 2024-04-25T01:19:42Z
format Article
id doaj.art-d259241bf6ca46faaee2ac9e829f486b
institution Directory Open Access Journal
issn 2949-7744
language English
last_indexed 2024-04-25T01:19:42Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Genetics in Medicine Open
spelling doaj.art-d259241bf6ca46faaee2ac9e829f486b2024-03-09T09:30:04ZengElsevierGenetics in Medicine Open2949-77442024-01-012100906P029: Early treatment with alglucosidase alfa is associated with improved survival in patients with infantile-onset Pompe disease: Data from Pompe RegistryPriya Kishnani0David Stockton1Andreas Hahn2Juan Llerena3Alexander Broomfield4Julie Batista5Meredith Foster6Kathryn Wilson7Susan Sparks8Hannerieke van den Hout9Yin-Hsiu Chien10Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NCDivision of Genetic, Genomic and Metabolic Disorders, Discipline of Pediatrics, Central Michigan University and Children's Hospital of Michigan, Detroit, MIDepartment of Child Neurology, University Hospital Giessen, Giessen, GermanyCentro de Genética Médica, Instituto Fernandes Figueira/FIOCRUZ, Rio de Janeiro, BrazilGreat Ormond Street Hospital, London, UKSanofi, Cambridge, MASanofi, Cambridge, MASanofi, Cambridge, MASanofi, Cambridge, MADivision of Metabolic Diseases and Genetics, Department of Pediatrics, Erasmus University Medical Center-Sophia, Rotterdam, The NetherlandsDepartment of Medical Genetics and Pediatrics, National Taiwan University Hospital, Taipei, Taiwanhttp://www.sciencedirect.com/science/article/pii/S2949774424000529
spellingShingle Priya Kishnani
David Stockton
Andreas Hahn
Juan Llerena
Alexander Broomfield
Julie Batista
Meredith Foster
Kathryn Wilson
Susan Sparks
Hannerieke van den Hout
Yin-Hsiu Chien
P029: Early treatment with alglucosidase alfa is associated with improved survival in patients with infantile-onset Pompe disease: Data from Pompe Registry
Genetics in Medicine Open
title P029: Early treatment with alglucosidase alfa is associated with improved survival in patients with infantile-onset Pompe disease: Data from Pompe Registry
title_full P029: Early treatment with alglucosidase alfa is associated with improved survival in patients with infantile-onset Pompe disease: Data from Pompe Registry
title_fullStr P029: Early treatment with alglucosidase alfa is associated with improved survival in patients with infantile-onset Pompe disease: Data from Pompe Registry
title_full_unstemmed P029: Early treatment with alglucosidase alfa is associated with improved survival in patients with infantile-onset Pompe disease: Data from Pompe Registry
title_short P029: Early treatment with alglucosidase alfa is associated with improved survival in patients with infantile-onset Pompe disease: Data from Pompe Registry
title_sort p029 early treatment with alglucosidase alfa is associated with improved survival in patients with infantile onset pompe disease data from pompe registry
url http://www.sciencedirect.com/science/article/pii/S2949774424000529
work_keys_str_mv AT priyakishnani p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT davidstockton p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT andreashahn p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT juanllerena p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT alexanderbroomfield p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT juliebatista p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT meredithfoster p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT kathrynwilson p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT susansparks p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT hanneriekevandenhout p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry
AT yinhsiuchien p029earlytreatmentwithalglucosidasealfaisassociatedwithimprovedsurvivalinpatientswithinfantileonsetpompediseasedatafrompomperegistry